In the Beat AML dataset, FCN1 exhibited notable associations with clinical relapse, disease transformation, FAB blast subtype, FLT3-ITD mutations, and NPM1 mutations (Figure 6D; Supplementary Figure S12D). This evidence concerns the gene FLT3 and acute myeloid leukemia.